Wellington Management Group LLP Buys 44,700 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Wellington Management Group LLP boosted its position in shares of Stevanato Group S.p.A. (NYSE:STVN) by 8.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 583,875 shares of the company’s stock after purchasing an additional 44,700 shares during the quarter. Wellington Management Group LLP’s holdings in Stevanato Group were worth $15,934,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. First Light Asset Management LLC increased its holdings in shares of Stevanato Group by 24.8% in the 4th quarter. First Light Asset Management LLC now owns 729,961 shares of the company’s stock worth $19,921,000 after purchasing an additional 145,206 shares in the last quarter. Intrinsic Edge Capital Management LLC bought a new position in Stevanato Group during the 4th quarter valued at about $3,076,000. Personal CFO Solutions LLC boosted its holdings in shares of Stevanato Group by 4.6% during the 4th quarter. Personal CFO Solutions LLC now owns 12,186 shares of the company’s stock valued at $333,000 after acquiring an additional 534 shares during the last quarter. Sands Capital Management LLC grew its stake in shares of Stevanato Group by 1.6% in the fourth quarter. Sands Capital Management LLC now owns 1,884,330 shares of the company’s stock worth $51,423,000 after acquiring an additional 29,450 shares during the period. Finally, Comgest Global Investors S.A.S. raised its holdings in shares of Stevanato Group by 88.5% during the fourth quarter. Comgest Global Investors S.A.S. now owns 129,309 shares of the company’s stock valued at $3,529,000 after purchasing an additional 60,707 shares during the last quarter.

Stevanato Group Trading Down 0.3 %

Shares of NYSE:STVN opened at €17.16 ($18.45) on Thursday. Stevanato Group S.p.A. has a 12-month low of €16.56 ($17.81) and a 12-month high of €36.30 ($39.03). The company has a market cap of $5.07 billion, a PE ratio of 31.20, a price-to-earnings-growth ratio of 3.08 and a beta of 0.61. The stock has a 50 day moving average of €21.64 and a 200 day moving average of €26.97. The company has a current ratio of 1.92, a quick ratio of 1.35 and a debt-to-equity ratio of 0.21.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings data on Thursday, May 9th. The company reported €0.09 ($0.10) EPS for the quarter, missing the consensus estimate of €0.12 ($0.13) by (€0.03) (($0.03)). The firm had revenue of €256.24 million for the quarter, compared to the consensus estimate of €261.28 million. Stevanato Group had a net margin of 12.57% and a return on equity of 12.61%. As a group, equities research analysts expect that Stevanato Group S.p.A. will post 0.54 EPS for the current year.

Stevanato Group Announces Dividend

The firm also recently announced an annual dividend, which will be paid on Monday, July 15th. Investors of record on Tuesday, June 4th will be given a dividend of $0.053 per share. This represents a dividend yield of 0.29%. The ex-dividend date of this dividend is Tuesday, June 4th. Stevanato Group’s dividend payout ratio is currently 10.91%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on STVN. BNP Paribas assumed coverage on shares of Stevanato Group in a research note on Monday, April 22nd. They set an “outperform” rating for the company. Morgan Stanley reissued an “equal weight” rating and issued a $30.00 target price on shares of Stevanato Group in a report on Monday, April 22nd. Finally, Stephens restated an “overweight” rating and set a $38.00 price target on shares of Stevanato Group in a research note on Monday, March 25th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, Stevanato Group currently has a consensus rating of “Moderate Buy” and a consensus price target of €34.17 ($36.74).

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.